Gene Biotherapeutics, Inc. Notes Payable, Noncurrent
Gene Biotherapeutics, Inc. had Notes Payable, Noncurrent of $26.21 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2022-04-14
- 2020-12-31: Notes Payable, Noncurrent $26.21K.
- 2020-09-30: Notes Payable, Noncurrent $25.66K.
- 2020-06-30: Notes Payable, Noncurrent $274.58K.
- 2020-03-31: Notes Payable, Noncurrent $245.74K.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2020-12-31 | $26.21K 10-K/A · filed 2022-04-14 |
| 2020-09-30 | $25.66K 10-Q · filed 2021-10-27 |
| 2020-06-30 | $274.58K 10-Q · filed 2021-09-17 |
| 2020-03-31 | $245.74K 10-Q · filed 2021-09-03 |
| 2019-12-31 | $122.21K 10-K/A · filed 2022-04-14 |